Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The extracellular domain (p75ECD) of p75 neurotrophin receptor (p75NTR) antagonizes Aβ neurotoxicity and promotes Aβ clearance in Alzheimer's disease (AD). The impaired shedding of p75ECD is a key pathological process in AD, but its regulatory mechanism is largely unknown. This study was designed to investigate the presence and alterations of naturally-occurring autoantibodies against p75ECD (p75ECD-NAbs) in AD patients and their effects on AD pathology. We found that the cerebrospinal fluid (CSF) level of p75ECD-NAbs was increased in AD, and negatively associated with the CSF levels of p75ECD. Transgenic AD mice actively immunized with p75ECD showed a lower level of p75ECD and more severe AD pathology in the brain, as well as worse cognitive functions than the control groups, which were immunized with Re-p75ECD (the reverse sequence of p75ECD) and phosphate-buffered saline, respectively. These findings demonstrate the impact of p75ECD-NAbs on p75NTR/p75ECD imbalance, providing a novel insight into the role of autoimmunity and p75NTR in AD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905456 | PMC |
| http://dx.doi.org/10.1007/s12264-022-00936-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Berberine as a natural immunomodulator of B lymphocytes.
Inflammopharmacology
August 2025
Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran.
B lymphocytes play crucial roles in host immune responses by mediating humoral immunity via the production of various types of antibodies and also contribute to the pathogenesis of a wide range of inflammatory, autoimmune, and neoplastic disorders. Recently, considerable literature has grown around the naturally occurring compounds immunomodulatory potential. In this regard, berberine (BBR) is an isoquinoline alkaloid with unique pharmacological actions including anti-inflammatory, anti-oxidant, anti-microbial, and anti-tumor activity, which arises from its polytrophic pharmacological and biochemical properties.
View Article and Find Full Text PDFThe role of autoantibodies in Alzheimer's disease: Pathogenetic connections or epiphenomena?
Alzheimers Dement
July 2025
Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Introduction: The current evidence supporting the complex, multifaceted etiology for Alzheimer's disease (AD) grows by the day, prompting increased research in non-"amyloid hypothesis"-related pathways. One of these pathways of interest pertains to an autoimmune component in this disease.
Methods: In this review, we briefly discuss current evidence of potential contributions of autoimmunity to AD pathobiology and describe the putative role of autoantibodies detected in patient fluids.
ICAM-1 autoantibodies detected in healthy individuals and cross-react with functional epitopes.
Immunohorizons
May 2025
Genomic Medicine Center, Children's Mercy Research Institute, Kansas City, MO, United States.
Intracellular adhesion molecule 1 (ICAM-1) is a cell surface glycoprotein that regulates cell-cell interactions, signaling, and immune processes. ICAM-1 expression has been shown to be elevated in many types of infections and inflammatory diseases. Strategies to block ICAM-1 function, including monoclonal anti-ICAM-1 antibodies, have been successful in treating the effects of chronic respiratory, autoimmune, and cardiovascular diseases.
View Article and Find Full Text PDFInflammatory arthritis immune related adverse events represent a unique autoimmune disease entity primarily driven by T cells, but likely not autoantibodies.
medRxiv
July 2025
Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Immune checkpoint inhibitor (ICI)-induced inflammatory arthritis (IA) is an increasingly recognized immune-related adverse event (irAE), yet its underlying immunopathogenesis remains poorly understood. Unlike rheumatoid arthritis (RA), where autoantibodies and B cell dysfunction are central features, the contribution of humoral immunity to IA irAE is unclear. Here, we performed in-depth immunophenotyping of peripheral blood from patients with IA irAE, and compared them with seronegative RA patients, ICI-treated patients without irAE, and healthy controls.
View Article and Find Full Text PDFAutoantibodies against α-synuclein inhibit its aggregation and cytotoxicity.
J Autoimmun
March 2025
Department of Neurology, Philipps-University Marburg, Rudolf-Bultmann Strasse 8, 35033, Marburg, Germany; Chair of Geriatric Medicine, University Duisburg-Essen, Essen, Germany. Electronic address:
Aggregates of α-synuclein (α-Syn) are the major component of the Lewy bodies associated with Parkinson's disease. Recently, naturally occurring autoantibodies against α-synuclein (α-Syn-nAbs) were detected. Herein we have isolated and further characterized such α-Syn-nAbs.
View Article and Find Full Text PDF